| Literature DB >> 27068711 |
Nobuyuki Araki1, Sonoko Misawa1, Kazumoto Shibuya1, Satoshi Ota2, Takashi Oide3, Asuka Kawano2, Minako Beppu1, Yukio Nakatani2,3, Satoshi Kuwabara4.
Abstract
BACKGROUND: Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis. The syndrome develops often in chronic hemodialysis patients. However, there have been several case reports on calciphylaxis in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome, a systemic disease associated with plasma cell dyscrasia and upregulation of vascular endothelial growth factor (VEGF).Entities:
Keywords: Calciphylaxis; Interleukin-6; POEMS syndrome; Vascular calcification; Vascular endothelial growth factor
Mesh:
Substances:
Year: 2016 PMID: 27068711 PMCID: PMC4828808 DOI: 10.1186/s13023-016-0421-3
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Fig. 1Findings in a patient with severe skin ulcers secondary to calciphylaxis. a Calciphylaxis-induced skin ulcers on admission. b Histology of biopsy specimen from the ulcer on the left thigh stained with hematoxylin and eosin stain (B1) and von Kossa stain (B2); Scale bars indicate 100 μm. Calcium deposits in the media of small- and medium-sized arteries. c Plain computed tomography showed multiple subcutaneous and intramuscular calcifications in the soft tissue of the thighs
Vascular calcification and risk factors
| POEMS syndrome | Disease control |
| |
|---|---|---|---|
| ( | ( | ||
| Gender; men:women | 52:23 | 62:24 | 0.70 |
| Age (years); mean (SD) | 57 (11) | 59 (14) | 0.19 |
| Calciphylaxis | |||
| Skin ulcer (%) | 4 % | 0 % | 0.097 |
| CTa | 17 % | 0 % | 0.00079 |
| Vascular risk factor | |||
| Diabetes | 19 % | 20 % | 0.86 |
| Hypertension | 33 % | 29 % | 0.56 |
| Hyperlipidemia | 31 % | 45 % | 0.056 |
Disease controls include patients with various neurodegenerative or inflammatory diseases (see text)
aSmall vessel calcification in the soft tissue of the hip/thigh
Fig. 2Findings of calcification on computed tomography (CT). a Plain CT of a POEMS syndrome patient with calciphylaxis. b The same CT changes in a chronic hemodialysis patient. c CT of a POEMS syndrome patient with no calcifications. d Ring-like calcification and occlusion of subcutaneous arterioles of an autopsy case. Autopsy case skin samples were obtained from a grossly normal lesion. Medial thickening and intimal loose fibrous proliferation caused arteriolar occlusion without any inflammation as seen on hematoxylin and eosin staining. e Calcification in the tunica media of arterioles as seen with von Kossa staining; Scale bars indicate 100 μm
Clinical and laboratory profiles of POEMS Syndrome Patients with and without calciphylaxis
| Calciphylaxis |
| ||
|---|---|---|---|
| Present ( | Absent ( | ||
| Gender; men:women | 12:1 | 40:22 | 0.043* |
| Age (years); mean (SD) | 58 (11) | 57 (11) | 0.89 |
| Disease duration | 3.1 (2.0) | 2.9 (3.3) | 0.21 |
| ONLS Leg score >5 | 46 % | 18 % | 0.042* |
| Pleural effusion | 54 % | 40 % | 0.28 |
| Ascites | 54 % | 13 % | 0.0028* |
| Laboratory data | |||
| VEGF (pg/ml) | 4100 (3100) | 5100 (5500) ( | 1.0 |
| TNF-α (pg/ml) | 18 (24) ( | 8.9 (11) ( | 0.22 |
| IL-6 (pg/ml) | 12 (4.4) ( | 4.4 (2.1) ( | 0.0013* |
| Cre (mg/dl) | 0.86 (0.45) | 0.94 (0.65) | 0.83 |
| Ca (mg/dl) | 9.0 (0.48) | 8.8 (0.42) | 0.19 |
| I-P (mg/dl) | 4.1 (0.98) ( | 4.0 (1.2) ( | 0.88 |
| Ca × I-P (mg2/dl2) | 36 (8.4) ( | 36 (9.9) ( | 0.89 |
| Albumin (g/dl) | 3.1 (0.44) | 3.7 (0.54) | 0.00035* |
| Plt (103/μl) | 260 (130) | 310 (160) | 0.21 |
| Treatment | |||
| Corticosteroid | 62 % | 53 % | 0.58 |
| Thalidomide | 15 % | 8 % | 0.35 |
| Melphalan | 8 % | 19 % | 0.29 |
| PBSCT | 15 % | 3 % | 0.14 |
Data are shown as mean (SD). ONLS, Overall Neuropathy Limitation Scale; VEGF, vascular endothelial growth factor; TNF-α: tumor necrosis factor-α; IL-6: Interleukin-6;
Ca, serum concentration of calcium corrected by albumin concentration; I-P, serum concentration of phosphate; Plt, platelet count; PBSCT: peripheral blood stem cell transplantation
*: p<0.05